Table 4 Review of our and previous retrospective studies of prognostic factors in DAH
Authors (year) | Prost [2] | Rabe [3] | Otoshi [9] | Mirouse [5] | Ours |
|---|---|---|---|---|---|
Participants of studies | |||||
Patients number, n | 97 | 37 | 76 | 104 | 68 |
Patients with AT, n | Not described | Not described | 39 | Not described | 48 |
IMV, n (%) | 17 (18%) | 32 (86%) | Not described | 52 (50%) | 38 (56%) |
Mortality rate, n (%) | 24 (25%) | 19 (51%) | 29 (38%) | 16 (15%) | 18 (27%) |
Factors associated with mortality | |||||
Univariate analyses | |||||
Demographics | Age | – | – | Age | – |
Comorbidities | CVD | – | Cardiac failure | Cardiac failure | – |
AT | – | – | Complicated DAH-AT a | – | Complicated DAH-AT a |
Etiologies | – | Classical DAH b | – | APS | Idiopathic DAH |
Clinical findings | Shock | Oxygen index, MODS | P/F ratio | SAPS II, Oxygen flow, P/F ratio | Oxygen flow |
Serum findings | Hb, LDH, eGFR | – | – | Lymphocytes | eGFR |
BALF findings | – | – | – | – | Neutrophils, Lymphocytes |
Others | Smoking (> 20 pack-years) | – | – | – | – |
Multivariate analyses | |||||
Shock, LDH, eGFR | Classical DAH | P/F ratio, Simple, DAH-AT | Cardiac failure, APS, SAPS II, Oxygen flow | – | |